Literature DB >> 21193909

CD8 co-receptor promotes susceptibility of CD8+ T cells to transforming growth factor-β (TGF-β)-mediated suppression.

Andrew Zloza1, Michael C Jagoda, Gretchen E Lyons, Michael C Graves, Frederick J Kohlhapp, Jeremy A O'Sullivan, Andrew T Lacek, Michael I Nishimura, José A Guevara-Patiño.   

Abstract

CD8+ T cell function depends on a finely orchestrated balance of activation/suppression signals. While the stimulatory role of the CD8 co-receptor and pleiotropic capabilities of TGF-β have been studied individually, the influence of CD8 co-receptor on TGF-β function in CD8+ T cells is unknown. Here, we show that while CD8 enhances T cell activation, it also enhances susceptibility to TGF-β-mediated immune suppression. Using Jurkat cells expressing a full-length, truncated or no αβCD8 molecule, we demonstrate that cells expressing full-length αβCD8 were highly susceptible, αβCD8-truncated cells were partially susceptible, and CD8-deficient cells were completely resistant to suppression by TGF-β. Additionally, we determined that inhibition of Lck rendered mouse CD8+ T cells highly resistant to TGF-β suppression. Resistance was not associated with TGF-β receptor expression but did correlate with decreased Smad3 and increased Smad7 levels. These findings highlight a previously unrecognized third role for CD8 co-receptor which appears to prepare activated CD8+ T cells for response to TGF-β. Based on the important role which TGF-β-mediated suppression plays in tumor immunology, these findings unveil necessary considerations in formulation of CD8+ T cell-related cancer immunotherapy strategies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21193909      PMCID: PMC4507403          DOI: 10.1007/s00262-010-0962-6

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  30 in total

Review 1.  Jurkat T cells and development of the T-cell receptor signalling paradigm.

Authors:  Robert T Abraham; Arthur Weiss
Journal:  Nat Rev Immunol       Date:  2004-04       Impact factor: 53.106

2.  Requirement for association of p56lck with CD4 in antigen-specific signal transduction in T cells.

Authors:  N Glaichenhaus; N Shastri; D R Littman; J M Turner
Journal:  Cell       Date:  1991-02-08       Impact factor: 41.582

3.  Identification of a hepatitis C virus-reactive T cell receptor that does not require CD8 for target cell recognition.

Authors:  Glenda G Callender; Hugo R Rosen; Jeffrey J Roszkowski; Gretchen E Lyons; Mingli Li; Tamson Moore; Natasha Brasic; Mark D McKee; Michael I Nishimura
Journal:  Hepatology       Date:  2006-05       Impact factor: 17.425

4.  Regulation of Lck activity by CD4 and CD28 in the immunological synapse.

Authors:  Amy D Holdorf; Kyeong-Hee Lee; W Richard Burack; Paul M Allen; Andrey S Shaw
Journal:  Nat Immunol       Date:  2002-02-04       Impact factor: 25.606

5.  Cell-cell adhesion mediated by CD8 and MHC class I molecules.

Authors:  A M Norment; R D Salter; P Parham; V H Engelhard; D R Littman
Journal:  Nature       Date:  1988-11-03       Impact factor: 49.962

6.  Influence of human CD8 on antigen recognition by T-cell receptor-transduced cells.

Authors:  Gretchen E Lyons; Tamson Moore; Natasha Brasic; Mingli Li; Jeffrey J Roszkowski; Michael I Nishimura
Journal:  Cancer Res       Date:  2006-12-01       Impact factor: 12.701

7.  TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance.

Authors:  Dori A Thomas; Joan Massagué
Journal:  Cancer Cell       Date:  2005-11       Impact factor: 31.743

8.  The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck.

Authors:  A Veillette; M A Bookman; E M Horak; J B Bolen
Journal:  Cell       Date:  1988-10-21       Impact factor: 41.582

Review 9.  Transforming growth factor-beta regulation of immune responses.

Authors:  Ming O Li; Yisong Y Wan; Shomyseh Sanjabi; Anna-Karin L Robertson; Richard A Flavell
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

10.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  6 in total

1.  NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responses.

Authors:  Andrew Zloza; Frederick J Kohlhapp; Gretchen E Lyons; Jason M Schenkel; Tamson V Moore; Andrew T Lacek; Jeremy A O'Sullivan; Vineeth Varanasi; Jesse W Williams; Michael C Jagoda; Emily C Bellavance; Amanda L Marzo; Paul G Thomas; Biljana Zafirova; Bojan Polić; Lena Al-Harthi; Anne I Sperling; José A Guevara-Patiño
Journal:  Nat Med       Date:  2012-02-26       Impact factor: 53.440

2.  Priming with very low-affinity peptide ligands gives rise to CD8(+) T-cell effectors with enhanced function but with greater susceptibility to transforming growth factor (TGF)β-mediated suppression.

Authors:  Jeremy A O'Sullivan; Andrew Zloza; Frederick J Kohlhapp; Tamson V Moore; Andrew T Lacek; Nickolai O Dulin; José A Guevara-Patiño
Journal:  Cancer Immunol Immunother       Date:  2011-06-17       Impact factor: 6.968

3.  A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice.

Authors:  Shikhar Mehrotra; Amir A Al-Khami; Jared Klarquist; Shahid Husain; Osama Naga; Jonathan M Eby; Anuradha K Murali; Gretchen E Lyons; Mingli Li; Natali D Spivey; Håkan Norell; Telma Martins da Palma; Georgiana Onicescu; C Marcela Diaz-Montero; Elizabeth Garrett-Mayer; David J Cole; I Caroline Le Poole; Michael I Nishimura
Journal:  J Immunol       Date:  2012-07-13       Impact factor: 5.422

4.  Evaluation of the immune factors in the tumor environment before and after the treatment of cetuximab combined with chemotherapy.

Authors:  Yanyun Zhu; Jie Li; Fangfang Jing; Tiefeng Ji; Xiaoqin Guo; Junlan Yang; Shunchang Jiao
Journal:  World J Surg Oncol       Date:  2013-09-13       Impact factor: 2.754

5.  Response of human normal and leukemia cells to factors released by amnion fragments in vitro.

Authors:  Zofia Grzywocz; Grazyna Hoser; Stanislawa Sabalinska; Piotr Ladyzynski; Jaroslaw Czubak; Malgorzata Dworczynska; Romuald Debski; Ewa Pius-Sadowska; Boguslaw Machalinski; Jerzy Kawiak
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

Review 6.  Tumor promoting roles of IL-10, TGF-β, IL-4, and IL-35: Its implications in cancer immunotherapy.

Authors:  Bhalchandra Mirlekar
Journal:  SAGE Open Med       Date:  2022-01-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.